Nothing Special   »   [go: up one dir, main page]

DE69823994D1 - 8-AZABICYCLO (3,2,1) OCT-2-EN AND OCTANE DERIVATIVES AS LIGANDS OF THE NICOTINERGEN AND RECEPTORS - Google Patents

8-AZABICYCLO (3,2,1) OCT-2-EN AND OCTANE DERIVATIVES AS LIGANDS OF THE NICOTINERGEN AND RECEPTORS

Info

Publication number
DE69823994D1
DE69823994D1 DE69823994T DE69823994T DE69823994D1 DE 69823994 D1 DE69823994 D1 DE 69823994D1 DE 69823994 T DE69823994 T DE 69823994T DE 69823994 T DE69823994 T DE 69823994T DE 69823994 D1 DE69823994 D1 DE 69823994D1
Authority
DE
Germany
Prior art keywords
thienyl
azabicyclo
oct
benzofuryl
benzothienyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69823994T
Other languages
German (de)
Other versions
DE69823994T2 (en
Inventor
Dan Peters
M Olsen
Simon Feldbaek Nielsen
Stergaard Nielsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NTG Nordic Transport Group AS
Original Assignee
Neurosearch AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch AS filed Critical Neurosearch AS
Publication of DE69823994D1 publication Critical patent/DE69823994D1/en
Application granted granted Critical
Publication of DE69823994T2 publication Critical patent/DE69823994T2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Psychology (AREA)
  • Pulmonology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nutrition Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)

Abstract

The invention disclosed herein relates to novel a 8-azabicyclo[3.2.1]oct-2-ene compound of Formula II, wherein R is hydrogen, methyl, ethyl or benzyl; and R<SUP>1 </SUP>is 3-thienyl, 2-thienyl, 2-(3-methoxymethyl), 3-quinolinyl, 3-benzofuryl, 2-benzofuryl, 3-benzothienyl, 2-benzothienyl, 2-benzothiazolyl, 2-thieno[3.2-b]thienyl, thieno[2.3-b]thienyl, 2-(3-bromo)benzofuryl or 2-(3-bromo)benzothienyl. These compounds are useful for the treatment of conditions or disorders involving the cholinergic system of the central nervous system, pain, inflammatory diseases, diseases caused by smooth muscle contractions and in the cessation of chemical substance abuse.
DE69823994T 1997-05-30 1998-05-29 8-AZABICYCLO (3,2,1) OCT-2-EN- AND OCTANDERIVATES AS LIGANDS OF THE NICOTINERGEN ACH RECEPTORS Expired - Lifetime DE69823994T2 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
DK62797 1997-05-30
DK62797 1997-05-30
DK150297 1997-12-19
DK150297 1997-12-19
DK40898 1998-03-24
DK40898 1998-03-24
DK53498 1998-04-16
DK53498 1998-04-16
PCT/DK1998/000225 WO1998054181A1 (en) 1997-05-30 1998-05-29 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors

Publications (2)

Publication Number Publication Date
DE69823994D1 true DE69823994D1 (en) 2004-06-24
DE69823994T2 DE69823994T2 (en) 2009-09-24

Family

ID=27439314

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69823994T Expired - Lifetime DE69823994T2 (en) 1997-05-30 1998-05-29 8-AZABICYCLO (3,2,1) OCT-2-EN- AND OCTANDERIVATES AS LIGANDS OF THE NICOTINERGEN ACH RECEPTORS

Country Status (23)

Country Link
US (2) US6645977B1 (en)
EP (1) EP0984965B1 (en)
JP (1) JP4447663B2 (en)
KR (1) KR100589872B1 (en)
CN (1) CN1157392C (en)
AT (1) ATE267199T1 (en)
AU (1) AU745964B2 (en)
BR (1) BR9809697A (en)
CA (1) CA2289574C (en)
CZ (1) CZ298824B6 (en)
DE (1) DE69823994T2 (en)
DK (1) DK0984965T3 (en)
EE (1) EE04057B1 (en)
HK (1) HK1027353A1 (en)
HU (1) HUP0002713A3 (en)
IL (2) IL132437A0 (en)
IS (1) IS2092B (en)
NO (1) NO325513B1 (en)
NZ (1) NZ500642A (en)
RU (1) RU2186780C2 (en)
SK (1) SK284994B6 (en)
TR (1) TR199902942T2 (en)
WO (1) WO1998054181A1 (en)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6350758B1 (en) * 1996-12-02 2002-02-26 Georgetown University Tropane derivatives and method for their synthesis
JP2002518331A (en) 1998-06-19 2002-06-25 イーライ・リリー・アンド・カンパニー Inhibition of serotonin reuptake
US6218383B1 (en) * 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
ATE259804T1 (en) 1998-11-27 2004-03-15 Neurosearch As 8-AZABICYCLO(3.2.1)OCT-2-EN AND OCTANE DERIVATIVES
US6432975B1 (en) 1998-12-11 2002-08-13 Targacept, Inc. Pharmaceutical compositions and methods for use
US6953855B2 (en) 1998-12-11 2005-10-11 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
DE60007841T2 (en) 1999-01-28 2004-07-08 Neurosearch A/S NEW AZABICYCLO DERIVATIVES AND THEIR USE
CA2361525C (en) * 1999-01-29 2009-12-08 Abbott Laboratories Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
US7265115B2 (en) 1999-01-29 2007-09-04 Abbott Laboratories Diazabicyclic CNS active agents
WO2000066586A1 (en) * 1999-05-04 2000-11-09 Neurosearch A/S Heteroaryl diazabicycloalkanes, their preparation and use
US6890935B2 (en) 1999-11-01 2005-05-10 Targacept, Inc. Pharmaceutical compositions and methods for use
MY145722A (en) * 2000-04-27 2012-03-30 Abbott Lab Diazabicyclic central nervous system active agents
MXPA03000053A (en) * 2000-07-04 2003-09-25 Neurosearch As Aryl and heteroaryl diazabicycloalkanes, their preparation and use.
CA2425638C (en) 2000-10-13 2011-04-05 Neurosearch A/S Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
SK1562004A3 (en) * 2001-10-02 2005-05-05 Pharmacia & Upjohn Company Azabicyclic-substituted fused-heteroaryl compounds for the treatment of diseases
DE10164139A1 (en) 2001-12-27 2003-07-10 Bayer Ag 2-heteroaryl carboxamides
BR0307735A (en) 2002-02-19 2005-01-25 Upjohn Co Fused Bicyclic N-Bridged Heteroaromatic Carboxamides for Disease Treatment
JP2005524712A (en) 2002-05-07 2005-08-18 ニューロサーチ、アクティーゼルスカブ Novel azacycloethynyl derivatives
DE602004013427T2 (en) * 2003-02-28 2009-06-04 Schering Corp. BIARYLTETRAHYDROISOCHINOLINE PIPERIDINE AS SELECTIVE MCH RECEPTOR ANTAGONISTS FOR THE TREATMENT OF ADIPOSITAS AND RELATED DISEASES
KR20070074667A (en) 2003-03-12 2007-07-12 화이자 프로덕츠 인크. Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
AU2005284908B2 (en) 2004-09-13 2011-12-08 Morningside Venture Investments Limited Biosynchronous transdermal drug delivery
US20060173037A1 (en) * 2005-01-10 2006-08-03 Nathalie Schlienger Aminophenyl derivatives as selective androgen receptor modulators
ATE495178T1 (en) 2005-02-16 2011-01-15 Neurosearch As DIAZABICYCLIC ARYL DERIVATIVES AND THEIR USE AS QUINOLINERGIC LIGANDS ON NICOTINE-ACETYLCHOLINE RECEPTORS
KR20070116867A (en) * 2005-04-08 2007-12-11 뉴로서치 에이/에스 (+)- and (-)-8-alkyl-3-(trifluoralkylsulfonyloxy)-8-azabicycl(3.2.1)oct-2-ene
FR2889701B1 (en) * 2005-08-12 2007-10-05 Sanofi Aventis Sa 5-PYRIDINYL-1-AZABICYCLO [3.2.1] OCTANE DERIVATIVES, THEIR PREPARATION IN THERAPEUTICS.
CN101305004B (en) 2005-12-06 2011-11-16 神经研究公司 Novel diazabicyclic aryl derivatives and their medical use
US20070134169A1 (en) * 2005-12-11 2007-06-14 Rabinoff Michael D Methods for smoking cessation or alcohol cessation or other addiction cessation
CN101379063A (en) 2006-02-10 2009-03-04 神经研究公司 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
EP1987031A1 (en) 2006-02-10 2008-11-05 NeuroSearch A/S 3-heteroaryl- 3,9-diazabicyclo[3.3.1]nonane derivatives as nicotinic acetylcholine receptor agonists
EP1984366B1 (en) 2006-02-10 2010-12-15 NeuroSearch A/S 3, 9-diazabicyclo ý3.3. 1¨nonane derivatives and their use as monoamine?neurotransmitter re-uptake inhibitors
KR20110075044A (en) 2007-04-02 2011-07-05 파킨슨즈 인스티튜트 Methods and compositions for reduction of side effects of therapeutic treatments
TWI415850B (en) * 2007-07-20 2013-11-21 Theravance Inc Process for preparing an intermediate to mu opioid receptor antagonists
SA08290475B1 (en) 2007-08-02 2013-06-22 Targacept Inc (2S,3R)-N-(2-((3-Pyridinyl)Methyl)-1-Azabicyclo[2.2.2]Oct-3-yl)Benzofuran-2-Carboxamide, Novel Salt forms, and Methods of Use Thereof
US8697722B2 (en) * 2007-11-02 2014-04-15 Sri International Nicotinic acetylcholine receptor modulators
JP5421368B2 (en) * 2008-08-01 2014-02-19 パーデュー、ファーマ、リミテッド、パートナーシップ Tetrahydropyridinyl and dihydropyrrolyl compounds and their use
US8633218B2 (en) * 2008-11-18 2014-01-21 Aniona Aps 8-azabicyclo[3.2.1]oct-2-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US8642638B2 (en) 2008-11-19 2014-02-04 Envivo Pharmaceuticals, Inc. Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
TW201031664A (en) 2009-01-26 2010-09-01 Targacept Inc Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
PE20120324A1 (en) * 2009-05-11 2012-04-17 Envivo Pharmaceuticals Inc COMBINATION INCLUDING (R) -7-CHLORO-N- (QUINUCLIDIN-3-IL) BENZO [B] THIOPHENE-2-CARBOXAMIDE AND DONEZEPYL AS A MODULATOR OF COGNITIVE DISORDERS
RU2560729C2 (en) 2010-01-11 2015-08-20 АСТРАЕА ТЕРАПЕУТИКС, ЭлЭлСи Modulators of nicotinic acetylcholine receptors
KR101698250B1 (en) 2010-05-17 2017-01-19 포럼 파마슈티칼즈 인크. A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate
EP3461481A1 (en) 2012-05-08 2019-04-03 Forum Pharmaceuticals Inc. Methods of maintaining, treating or improving cognitive function
WO2014011768A1 (en) * 2012-07-10 2014-01-16 Adispell, Inc. Anti-anxiety treatment
JP2018511355A (en) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. Drug delivery method and system
US9724340B2 (en) 2015-07-31 2017-08-08 Attenua, Inc. Antitussive compositions and methods
AU2018205529B2 (en) 2017-01-06 2023-08-10 Morningside Venture Investments Limited Transdermal drug delivery devices and methods
CA3101966A1 (en) 2018-05-29 2019-12-05 Morningside Venture Investments Limited Drug delivery methods and systems
KR102272452B1 (en) 2020-12-11 2021-07-05 (주)예광솔라 Spiral pile constructing method and spiral pile applied by the same
KR200497569Y1 (en) 2021-02-18 2023-12-21 주식회사 알파인랩 Screw pile

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133073A (en) * 1959-12-10 1964-05-12 Sterling Drug Inc 3-aryl-1, 5-iminocycloalkanes and preparation thereof
US3657257A (en) * 1970-08-31 1972-04-18 Robins Co Inc A H 3-aryl-8-carbamoyl nortropanes
CA1244028A (en) * 1983-04-14 1988-11-01 Hans Maag Pyrimidine derivatives
GB9019973D0 (en) 1990-09-12 1990-10-24 Wyeth John & Brother Ltd Azabicyclic derivatives
US5045546A (en) 1990-10-26 1991-09-03 Hoechst-Roussel Pharmaceuticals Inc. 8-azabicyclo[3.2.1]octylalkylthiazolidines
NZ241481A (en) 1991-02-04 1994-06-27 Hoechst Roussel Pharma Derivatives of 8-aza-bicyclo[3.2.1]octane and pharmaceutical compositions thereof
ATE197454T1 (en) * 1991-05-29 2000-11-11 Abbott Lab ISOXAZOLE AND ISOTHIAZOLE COMPOUNDS THAT IMPROVE COGNITIVE FUNCTIONS
US5731317A (en) * 1995-03-10 1998-03-24 Merck & Co., Inc. Bridged piperidines promote release of growth hormone
GB9507203D0 (en) * 1995-04-07 1995-05-31 Smithkline Beecham Plc Novel compounds
JPH11512443A (en) * 1995-09-22 1999-10-26 ノボ ノルディスク アクティーゼルスカブ New substituted azacyclic or azabicyclic compounds
ATE362931T1 (en) * 1995-10-13 2007-06-15 Neurosearch As 8-AZABICYCLO(3.2.1)OCT-2EN DERIVATIVES, THEIR PRODUCTION AND APPLICATION
GB9706222D0 (en) * 1997-03-26 1997-05-14 Zeneca Ltd Bicyclic amine derivatives
EP0955301A3 (en) 1998-04-27 2001-04-18 Pfizer Products Inc. 7-aza-bicyclo[2.2.1]-heptane derivatives, their preparation and use according to their affinity for neuronal nicotinic acetylcholine receptors
JP2002518331A (en) * 1998-06-19 2002-06-25 イーライ・リリー・アンド・カンパニー Inhibition of serotonin reuptake

Also Published As

Publication number Publication date
IS2092B (en) 2006-04-12
IL132437A0 (en) 2001-03-19
US20040019207A1 (en) 2004-01-29
TR199902942T2 (en) 2000-04-21
AU745964B2 (en) 2002-04-11
KR100589872B1 (en) 2006-06-15
NO325513B1 (en) 2008-05-26
EE04057B1 (en) 2003-06-16
SK162699A3 (en) 2000-07-11
CN1157392C (en) 2004-07-14
HUP0002713A3 (en) 2001-02-28
EE9900529A (en) 2000-06-15
EP0984965A1 (en) 2000-03-15
DE69823994T2 (en) 2009-09-24
ATE267199T1 (en) 2004-06-15
NZ500642A (en) 2001-11-30
HUP0002713A2 (en) 2001-01-29
CN1257499A (en) 2000-06-21
AU7426198A (en) 1998-12-30
US6964972B2 (en) 2005-11-15
CA2289574A1 (en) 1998-12-03
IL132437A (en) 2006-12-10
NO995850L (en) 1999-11-29
DK0984965T3 (en) 2004-09-27
RU2186780C2 (en) 2002-08-10
EP0984965B1 (en) 2004-05-19
IS5243A (en) 1999-11-10
SK284994B6 (en) 2006-04-06
CA2289574C (en) 2007-04-24
BR9809697A (en) 2000-07-11
KR20010013154A (en) 2001-02-26
CZ414799A3 (en) 2000-02-16
HK1027353A1 (en) 2001-01-12
NO995850D0 (en) 1999-11-29
US6645977B1 (en) 2003-11-11
WO1998054181A1 (en) 1998-12-03
CZ298824B6 (en) 2008-02-20
JP4447663B2 (en) 2010-04-07
JP2002501514A (en) 2002-01-15

Similar Documents

Publication Publication Date Title
ATE267199T1 (en) 8-AZABICYCLO(3,2,1)OCT-2-EN AND OCTANE DERIVATIVES AS LIGANDS OF NICOTINERGENIC RECEPTORS
RU99128075A (en) DERIVATIVES OF 8-AZABICYCLO (3,2,1) OCT-2-ENA AND OCTANE AS CHOLINERGIC LIGANDS ON ACH RECEPTORS
US8624040B2 (en) Substituted hydroxamic acids and uses thereof
US7220756B2 (en) N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligands
CA2094332A1 (en) Urokinase inhibitors
ES2301045T3 (en) DERIVATIVES OF PIRIMIDO-BECIMIDAZOL AND ITS USE AS AGONISTS OR ANTAGONISTS OF THE RECEIVERS OF THE MELANOCORTINAS.
AU2004270470A1 (en) Thienopyrroles as antiviral agents
CA2521732A1 (en) Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists
ES2309398T3 (en) DERIVATIVES 3,4-DIHIDRO-TIENO (2,3-D) PIRIMIDIN-4-ONA-3-SUBSTITUTED, PRODUCTION AND ITS USES.
CS501387A2 (en) Process for preparing new derivatives of 1h,3h-pyrrolo-/1,2-c/thiazole
FI89049C (en) FOR TREATMENT OF THERAPEUTIC THERAPEUTIC PRODUCTS
JP2003524633A (en) Quinoline and naphthyridine carboxylic acid antibacterial agents
DK0534343T3 (en) Substituted pyridinylamino-1H-indoles, 1H-indazoles, 2H-indazoles, benzo [b] thiophenes and 1,2-benzoisothiazoles,
US20050209191A1 (en) 1-Aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
WO2010045008A1 (en) AMIDES OF THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
US4889848A (en) Tricyclic pyridine derivatives
Russell et al. Five-membered ring systems: Thiophenes & Se, Te analogs
Krutosíková et al. Recent Studies in Chemistry of Hetero Analogs of Pentalene Dianion
RU2000125685A (en) MODULATORS OF PROTEIN TYROSINPHOSPHATAS (PTF-AZ)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition